| 24939611
|
Oncolytic polio virotherapy of cancer. |
Cancer |
2014 |
Brown MC;Dobrikova EY;Dobrikov MI;Walton RW;Gemberling SL;Nair SK;Desjardins A;Sampson JH;Friedman HS;Friedman AH;Tyler DS;Bigner DD;Gromeier M |
View
More |
| 29997212
|
Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells. |
J Virol |
2018 |
Walton RW;Brown MC;Sacco MT;Gromeier M |
View
More |
| 30672366
|
Effect of Genetic Modifications on Physical and Functional Titers of Adenoviral Cancer Gene Therapy Constructs. |
Hum Gene Ther |
2019 |
Heinio C;Sorsa S;Siurala M;Gronberg-Vaha-Koskela S;Havunen R;Haavisto E;Koski A;Hemminki O;Zafar S;Cervera-Carrascon V;Munaro E;Kanerva A;Hemminki A |
View
More |
| 34208264
|
Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances. |
Viruses |
2021 |
Kwan A;Winder N;Muthana M |
View
More |
| 34242964
|
The spontaneous remission of cancer: Current insights and therapeutic significance. |
Transl Oncol |
2021 |
Radha G;Lopus M |
View
More |
| 34503272
|
Prior Exposure to Coxsackievirus A21 Does Not Mitigate Oncolytic Therapeutic Efficacy. |
Cancers (Basel) |
2021 |
Burnett WJ;Burnett DM;Parkman G;Ramstead A;Contreras N;Gravley W;Holmen SL;Williams MA;VanBrocklin MW |
View
More |
| 35674873
|
Oncolytic Viral Therapy for Malignant Glioma and Their Application in Clinical Practice. |
Neurotherapeutics |
2022 |
Shoaf ML;Desjardins A |
View
More |
